glp 1 and gip combination The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Novel Dual GIP and
Description
Yes, doctors can prescribe GLP-1 for weight loss when medical criteria are met
The positive phase 1 clinical trial for Viking Therapeutics Inc
Honeydew reports spironolactone, once a diuretic, is now a popular acne treatment due to its effectiveness in targeting hormonal acne with minimal side effects.
Conversely, this trend heralds a potential boom for producers of health-oriented products like protein shakes and meal replacements, indicating a realignment of consumer preferences towards weight-management foods
This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes
Key numbers (T2D, semaglutide vs matched controls): NAION RR at 1/3/5 yrs = 1.00 / 0.84 / 0.70
